Eton Pharmaceuticals, Inc. (ETON)

Eton Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 16, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	508	344	112	71	106	197
Market Cap Growth	261.35%	206.22%	57.54%	-32.42%	-46.38%	53.54%
Enterprise Value	520	328	96	64	90	197
Last Close Price	18.93	13.32	4.38	2.82	4.29	8.13
Forward PE	36.76	57.91	79.64	-	9.98	-
PS Ratio	10.25	8.82	3.55	3.36	4.84	5047.59
PB Ratio	20.76	14.09	7.26	5.46	5.99	12.57
P/TBV Ratio	-	-	10.47	8.57	7.54	13.05
P/FCF Ratio	91.97	364.94	16.49	14.92	-	-
P/OCF Ratio	91.77	355.15	16.49	14.80	-	-
EV/Sales Ratio	10.77	8.41	3.04	3.03	4.11	5040.62
EV/FCF Ratio	94.26	348.04	14.11	13.46	-	-
Debt / Equity Ratio	1.23	1.23	0.35	0.50	0.38	0.46
Debt / FCF Ratio	5.45	31.81	0.80	1.36	-	-
Asset Turnover	0.84	0.72	1.12	0.81	0.81	0.00
Inventory Turnover	2.52	1.93	14.42	12.53	3.16	0.54
Quick Ratio	1.33	1.02	1.53	2.81	4.36	5.63
Current Ratio	1.97	2.06	1.65	3.10	5.18	6.51
Return on Equity (ROE)	-22.95%	-19.16%	-6.56%	-58.75%	-11.74%	-213.40%
Return on Assets (ROA)	-2.02%	-2.53%	-2.63%	-19.67%	-3.47%	-78.10%
Return on Capital (ROIC)	-3.08%	-3.62%	-3.68%	-23.51%	-3.96%	-89.38%
Earnings Yield	-0.90%	-1.11%	-0.83%	-12.65%	-1.85%	-14.21%
FCF Yield	1.09%	0.27%	6.06%	6.71%	-4.48%	-11.38%
Buyback Yield / Dilution	-1.83%	-0.97%	-1.99%	0.24%	-19.98%	-18.30%

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q